I’m sure they want to do the same with J&J. The mRNA vaccines are faster to produce, so from a supply chain perspective, governments like that.
It also doesn’t help that Pfizer spends double its R&D budget on marketing. I wouldn’t be the least bit surprised all this media attention on competitor blood clots is related to some astroturfed campaigns from them.
All the deaths and adverse mRNA reactions in VAERS go totally unreported on, unless it’s to call it “fake news”.
The vaccine has been Pfizer’s number 1 product this year, accounting for 25% of its profits. They would love to be the only game in town when the passports become mandatory.
They’re racing to be the first to have fda approval (coming in a few months supposedly) so then they can be mandatory for government jobs and other roles (right now it’s still emergency use exceptions)
Both the EU and Canada have signed booster shot contracts for 2022 and 2023.
I’m sure they want to do the same with J&J. The mRNA vaccines are faster to produce, so from a supply chain perspective, governments like that.
It also doesn’t help that Pfizer spends double its R&D budget on marketing. I wouldn’t be the least bit surprised all this media attention on competitor blood clots is related to some astroturfed campaigns from them.
All the deaths and adverse mRNA reactions in VAERS go totally unreported on, unless it’s to call it “fake news”.
The vaccine has been Pfizer’s number 1 product this year, accounting for 25% of its profits. They would love to be the only game in town when the passports become mandatory.
They’re racing to be the first to have fda approval (coming in a few months supposedly) so then they can be mandatory for government jobs and other roles (right now it’s still emergency use exceptions)
Both the EU and Canada have signed booster shot contracts for 2022 and 2023.